These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2020 related articles for article (PubMed ID: 19766641)

  • 1. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
    Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
    Schuppan D; Dennis MD; Kelly CP
    Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiac disease--sandwiched between innate and adaptive immunity.
    Stepniak D; Koning F
    Hum Immunol; 2006 Jun; 67(6):460-8. PubMed ID: 16728270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
    Bodd M; Kim CY; Lundin KE; Sollid LM
    Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiac disease: caught between a rock and a hard place.
    Koning F
    Gastroenterology; 2005 Oct; 129(4):1294-301. PubMed ID: 16230082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
    Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
    Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future therapeutic options for celiac disease.
    Sollid LM; Khosla C
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):140-7. PubMed ID: 16265155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gluten sensitivity in the rectal mucosa of first-degree relatives of celiac disease patients.
    Dezi R; Niveloni S; Sugai E; Pedreira S; Smecuol E; Vazquez H; Doldan I; Cabanne A; Boerr L; Valero J; Kogan Z; Mauriño E; Bai JC
    Am J Gastroenterol; 1997 Aug; 92(8):1326-30. PubMed ID: 9260799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gluten tolerance in adult patients with celiac disease 20 years after diagnosis?
    Hopman EG; von Blomberg ME; Batstra MR; Morreau H; Dekker FW; Koning F; Lamers CB; Mearin ML
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):423-9. PubMed ID: 18403944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of celiac disease.
    Koning F
    J Mol Recognit; 2003; 16(5):333-6. PubMed ID: 14523946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiopathology and Management of Gluten-Induced Celiac Disease.
    Kumar J; Kumar M; Pandey R; Chauhan NS
    J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients.
    Diosdado B; Wijmenga C
    Expert Rev Mol Diagn; 2005 Sep; 5(5):681-700. PubMed ID: 16149872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.
    Ráki M; Molberg O; Tollefsen S; Lundin KE; Sollid LM
    Clin Exp Immunol; 2005 Nov; 142(2):333-40. PubMed ID: 16232221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
    Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.